Anandamide, an endogenous compound produced in the body, plays a role in reversing memories of traumatic events. The findings could lead to new treatments for PTSD. Read More
Advertisements
A variant of the FAAH gene increases vulnerability to THC in females and has a larger-scale impact on brain regions responsible for reward processing. Read More
When pregnant women consume diets high in polyunsaturated omega-6 fatty acids, an excess of endocannabinoids is produced which overloads the fetus, and impairs healthy brain development. Read More
Fatty acid amide hydrolase (FAAH) inhibitors, a form of medication that boosts endocannabinoids, may be helpful in the treatment of PTSD. FAAH inhibition can improve the recall of fear extinction memories. The drugs could also help treat stress and other psychological disorders. Read More
Moderate intensity exercise significantly boosts endocannabinoids and improves mood for those with major depressive disorder. Read More
While endocannabinoids have been reported to play a role in anti-inflammation in some areas of the brain, a new study reveals they may cause inflammation in the cerebellum. Read More
The secretory pathway delivery of cannabinoid type 1 receptor is axonally based, and surface expressed CB1R is more stable in axons than dendrites. Read More
Cannabis consumption during pregnancy is associated with a slightly increased risk of a child developing psychosis at age ten. The findings also shed new light on the role endocannabinoids play in neurodevelopment. Read More
A rare genetic mutation has been associated with pain insensitivity. The findings could further research into new treatments to target pain. Read More
Researchers shed light on the endocannabinoid system and report how cannabis is helping to provide relief to many with medical problems. Read More
Researchers report a new drug can help to reduce symptoms of cannabis withdrawal for those with cannabis use disorder. Read More
A new study reveals how dangerous inflammations in the brain are caused during the aging process. Researchers say failure with the CB1 to control activity of immune cells may result in chronic neuroinflammation. They say it may be possible to break this vicious cycle in the future with drugs that contain THC, which is a powerful CB1 receptor activator. Read More
